Association of the insulin-like growth factor1 gene with myocardial infarction in Japanese subjects

Hereditas

Volumn 147, Issue 5, 2010, Pages 215-224

  Aoi, Noriko ^a   Nakayama, Tomohiro ^a   Soma, Masayoshi ^a   Kosuge, Kotoko ^a   Haketa, Akira ^a   Sato, Mikano ^a   Sato, Naoyuki ^a   Asai, Satoshi ^a   Matsumoto, Koichi ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENETIC VARIABILITY; HAPLOTYPE; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; AGED, 80 AND OVER; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 78651471030     PISSN: 00180661     EISSN: 16015223     Source Type: Journal    
DOI: 10.1111/j.1601-5223.2010.02174.x     Document Type: Article

References (39)

1. Andreassen M., Raymond I., Kistorp C. et al. 2009. IGF1 as predictor of all cause mortality and cardiovascular disease in an elderly population. Eur. J. Endocrinol. 160: 25-31.
2. Balaram S. K., Agrawal D. K., Allen R. T. et al. 1997. Cell adhesion molecules and insulin-like growth factor-1 in vascular disease. J. Vasc. Surg. 25: 866-876.
3. Balaram S. K., Agrawal D. K. and Edwards J. D. 1999. Insulin like growth factor-1 activates nuclear factor-kappaB and increases transcription of the intercellular adhesion molecule-1 gene in endothelial cells. Cardiovasc. Surg. 7: 91-97.
4. Bar R. S., Boes M., Dake B. L. et al. 1988. Insulin, insulin-like growth factors, and vascular endothelium. Am. J. Med. 85(5A): 59-70.
5. Chao W., Matsui T., Novikov M. S. et al. 2003. Strategic advantages of insulin-like growth factor-I expression for cardioprotection. J. Gene Med. 5: 277-286.
6. Delafontaine P., Song Y.-H. and Li Y. 2004. Expression, regulation, and function of IGF-1, IGF-1R, and IGF-1 binding proteins in blood vessels. Arterioscler. Thromb. Vasc. Biol. 24: 435-444.
7. Dempster A. P., Laird N. M. and Rubin D. B. 1977. Maximum likelihood from in complete data via the EM algorithm. J. R. Stat. Soc. 39: 1-22.
8. Dunn S. E., Kari F. W., French J. et al. 1997. Dietary restriction reduces insulin-like growth factor I levels, which modulates apoptosis, cell proliferation, and tumor progression in p53-deficient mice. Cancer Res. 57: 4667-4672.
9. Fan W. Q., Yanase T., Morinaga H. et al. 2007. Insulin-like growth factor 1/insulin signaling activates androgen signaling through direct interactions of Foxo1 with androgen receptor. J. Biol. Chem. 282: 7329-7338.
10. Fu Z., Nakayama T., Sato N. et al. 2009. A haplotype of the CYP4F2 gene associated with myocardial infarction in Japanese men. Mol. Genet. Metab. 96: 145-147.
11. Gatto M., Drudi-Metalli V., Torrice A. et al. 2008. Insulin-like growth factor-1 isoforms in rat hepatocytes and cholangiocytes and their involvement in protection against cholestatic injury. Lab. Invest. 88: 986-994.
12. Hochberg Z., Hertz P., Maor G. et al. 1992. Growth hormone and insulin-like growth factor-I increase macrophage uptake and degradation of low density lipoprotein. Endocrinology 131: 430-435.
13. Horikawa Y., Oda N., Cox N. J. et al. 2000. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat. Genet. 26: 163-175.
14. Ioannidis J. P. A., Trikalinos T. A., Ntzani E. E. et al. 2003. Genetic associations in large versus small studies: an empirical assessment. Lancet 361: 567-571.
15. Janssen J. A., Stolk R. P., Pols H. A. et al. 1998. Serum total IGF-I, free IGF-I, and IGFB-1 levels in an elderly population: relation to cardiovascular risk factors and disease. Arterioscler. Thromb. Vasc. Biol. 18: 277-282.
16. Jones J. I. and Clemmons D. R. 1995. Insulin-like growth factors and their binding proteins: biological actions. Endocrin. Rev. 16: 3-34.
17. Juul A., Scheike T., Davidsen M. et al. 2002. Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study. Circulation 106: 939-944.
18. Kaneko Y., Nakayama T., Saito K. et al. 2006. Relationship between the thromboxane A2 receptor gene and susceptibility to cerebral infarction. Hypertens. Res. 29: 665-671.
19. Lanzino M., Morelli C., Garofalo C. et al. 2008. Interaction between estrogen receptor alpha and insulin/IGF signaling in breast cancer. Curr. Cancer Drug Targets 8: 597-610.
20. Li Q., Li B., Wang X. et al. 1997. Overexpression of insulin-like growth factor-1 in mice protects from myocyte death after infarction, attenuating ventricular dilation, wall stress, and cardiac hypertrophy. J. Clin. Invest. 100: 1991-1999.
21. Livak K. J., Marmaro J. and Todd J. A. 1995. Towards fully automated genome-wide polymorphism screening. Nat. Genet. 9: 341-342.
22. Mathews L. S., Norstedt G., Palmiter R. D. 1986. Regulation of insulin-like growth factor I gene expression by growth hormone. Proc. Natl Acad. Sci. USA 83: 9343-9347.
23. Meinel L., Zoidis E., Zapf J. et al. 2003. Localized insulin-like growth factor I delivery to enhance new bone formation. Bone 33: 660-672.
24. Morita A., Nakayama T. and Soma M. 2006. Association study between C-reactive protein genes and ischemic stroke in Japanese subjects. Am. J. Hypertens. 19: 593-600.
25. Morris R. W. and Kaplan N. L. 2002. On the advantage of haplotype analysis in the presence of multiple disease susceptibility alleles. Genet. Epidemiol. 23: 221-233.
26. Nakayama T., Soma M., Saito S. et al. 2003. Missense mutation of exon 3 in the type A human natriuretic peptide receptor gene is associated with myocardial infarction. Med. Sci. Monit. 9: CR505-CR510.
27. Okura Y., Brink M., Zahid A. A. et al. 2001. Decreased expression of insulin-like growth factor-1 and apoptosis of vascular smooth muscle cells in human atherosclerotic plaque. J. Mol. Cell Cardiol. 33: 1777-1789.
28. Pfeifle B. and Ditschuneit H. 1983. Receptors for insulin and insulin-like growth factor in cultured arterial smooth muscle cells depend on their growth state. J. Endocrinol. 96: 251-257.
29. Rajaram S., Baylink D. J. and Mohan S. 1997. Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions. Endocrinol. Rev. 18: 801-831.
30. Rietveld I., Janssen J. A. M. J. L., Hofman A. et al. 2003. A polymorphism in the IGF-I gene influences the age-related decline in circulating total IGF-I levels. Eur. J. Endocrinol. 148: 171-175.
31. Rotwein P., Pollock K. M., Didier D. K. et al. 1986. Organization and sequence of the human insulin-like growth factor I gene. Alternative RNA processing produces two insulin-like growth factor I precursor peptides. J. Biol. Chem. 261: 4828-4832.
32. Ruberte J., Ayuso E., Navarro M. et al. 2004. Increased ocular levels of IGF-1 in transgenic mice lead to diabetes-like eye disease. J. Clin. Invest. 113: 1149-1157.
33. Sussenbach J. S., Steenbergh P. H. and Holthuizen P. 1992. Structure and expression of the human insulin-like growth factor genes. Growth Regulators 2: 1-9.
34. Tivesten A., Bollano E., Andersson I. et al. 2002. Liver-derived insulin-like growth factor-I is involved in the regulation of blood pressure in mice. Endocrinology 143: 4235-4242.
35. Vaessen N., Heutink P., Janssen J. A. et al. 2001. A polymorphism in the gene for IGF-I: functional properties and risk for type 2 diabetes and myocardial infarction. Diabetes 50: 637-642.
36. Wilson V. J., Ward J. P., Burnand K. G. et al. 1996. Upregulation of IGF-I and collagen I mRNA in human atherosclerotic tissue is not accompanied by changes in type 1 IGF receptor or collagen III mRNA: an in situ hybridization study. Coron. Artery Dis. 7: 569-572.
37. Yazdanpanah M., Rietveld I., Janssen J. A. M. J. L. et al. 2006b. An insulin-like growth factor-I promoter polymorphism is associated with increased mortality in subjects with myocardial infarction in an elderly Caucasian population. Am. J. Cardiol. 97: 1274-1276.
38. Yazdanpanah M., Sayed-Tabatabaei F. A., Janssen J. A. M. J. L. et al. 2006a. IGF-I gene promoter polymorphism is a predictor of survival after myocardial infarction in patients with type 2 diabetes. Eur. J. Endocrinol. 155: 751-756.
39. Zhang W., Collins A. and Morton N. E. 2004. Does haplotype diversity predict power for association mapping of disease susceptibility? Hum. Genet. 115: 157-164.